US Patent Issued to Incyte on Sept. 15 for "Fused pyrazine derivatives as A2A / A2B inhibitors" (Pennsylvania, New Jersey, Delaware Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,424, issued on Sept. 15, was assigned to Incyte Corp. (Wilmington, Del.).

"Fused pyrazine derivatives as A2A / A2B inhibitors" was invented by Xiaozhao Wang (Mount Laurel, N.J.), Peter Niels Carlsen (Claymont, Del.), Pei Gan (Claymont, Del.), Gia Hoang (Wilmington, Del.), Yong Li (Newark, Del.), Chao Qi (Newark, Del.), Liangxing Wu (Wilmington, Del.), Wenqing Yao (Chadds Ford, Pa.), Zhiyong Yu (Wilmington, Del.) and Wenyu Zhu (Media, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to compounds of Formula (I):or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as subtypes...